Jpmorgan Chase & CO Idexx Laboratories Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 443,065 shares of IDXX stock, worth $289 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

443,065

Previous 537,438 17.56%

Holding current value

$289 Million

Previous $222 Million 16.26%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$406.29 - $469.04 $38.3 Million - $44.3 Million	-94,373 Reduced 17.56%	443,065 $186 Million
Q4 2024 Feb 12, 2025	SELL	$406.92 - $495.42 $30.6 Million - $37.3 Million	-75,234 Reduced 12.28%	537,438 $222 Million
Q3 2024 Dec 26, 2024	SELL	$455.08 - $517.19 $70.9 Million - $80.6 Million	-155,783 Reduced 20.27%	612,672 $309 Million
Q3 2024 Nov 08, 2024	SELL	$455.08 - $517.19 $73.8 Million - $83.9 Million	-162,243 Reduced 21.45%	594,000 $300 Million
Q2 2024 Dec 26, 2024	BUY	$468.04 - $548.53 $81.7 Million - $95.7 Million	174,455 Added 29.37%	768,455 $374 Million
Q2 2024 Aug 12, 2024	SELL	$468.04 - $548.53 $9.84 Million - $11.5 Million	-21,015 Reduced 2.7%	756,243 $368 Million
Q1 2024 Dec 26, 2024	BUY	$515.08 - $576.87 $101 Million - $113 Million	195,470 Added 32.91%	789,470 $426 Million
Q1 2024 May 10, 2024	SELL	$515.08 - $576.87 $42.9 Million - $48 Million	-83,221 Reduced 9.67%	777,258 $420 Million
Q4 2023 Dec 26, 2024	BUY	$391.37 - $557.56 $109 Million - $155 Million	278,691 Added 46.92%	872,691 $484 Million
Q4 2023 Feb 12, 2024	BUY	$391.37 - $557.56 $23.2 Million - $33 Million	59,205 Added 7.39%	860,479 $478 Million
Q3 2023 Nov 14, 2023	BUY	$432.42 - $556.67 $28.4 Million - $36.6 Million	65,760 Added 8.94%	801,274 $350 Million
Q2 2023 Aug 11, 2023	BUY	$450.7 - $503.61 $64.6 Million - $72.1 Million	143,261 Added 24.19%	735,514 $369 Million
Q1 2023 May 18, 2023	BUY	$406.01 - $514.59 $15.8 Million - $20 Million	38,960 Added 7.04%	592,253 $296 Million
Q1 2023 May 11, 2023	BUY	$406.01 - $514.59 $10.1 Million - $12.8 Million	24,897 Added 4.71%	553,293 $277 Million
Q4 2022 Feb 13, 2023	BUY	$324.64 - $441.27 $38.9 Million - $52.8 Million	119,729 Added 29.3%	528,396 $216 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $7.88 Million - $9.87 Million	-24,195 Reduced 5.59%	408,667 $133 Million
Q2 2022 Aug 11, 2022	BUY	$327.37 - $553.44 $16.7 Million - $28.2 Million	50,869 Added 13.32%	432,862 $152 Million
Q1 2022 May 11, 2022	BUY	$466.52 - $631.01 $58.4 Million - $78.9 Million	125,091 Added 48.69%	381,993 $209 Million
Q4 2021 Feb 10, 2022	BUY	$586.54 - $666.48 $4.44 Million - $5.05 Million	7,575 Added 3.04%	256,902 $169 Million
Q3 2021 Nov 12, 2021	BUY	$621.9 - $705.76 $155 Million - $176 Million	249,327 New	249,327 $155 Million

Others Institutions Holding IDXX

# of Institutions

1,341

Shares Held

75.8M

Call Options Held

126K

Put Options Held

214K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $54.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Idexx Laboratories Inc Transaction History